Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis
US9763908B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Sep 3, 2014 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Sep 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition, functional health food composition, quasi-drug composition, and cosmetic composition containing a monoacetyldiacylglycerol compound as an active ingredient for preventing, treating or improving atopic dermatitis. The monoacetyldiacylglycerol compound of the present invention has an excellent effect of suppression of IL-4 and IgE secretion, thereby overcoming side effects of an atopic dermatitis treatment agent currently in use, having no toxicity, and exhibiting an excellent treatment effect, and thus can be useful as a composition for preventing, treating, and ameliorating atopic dermatitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.